1994年至2000年间在法国分离出的96株炭疽芽孢杆菌的抗生素敏感性
Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.
作者信息
Cavallo Jean-Didier, Ramisse Francoise, Girardet Monique, Vaissaire Josée, Mock Michelle, Hernandez Eric
机构信息
Laboratoire de Biologie Médicale, Hôpital d'Instruction des Armées Bégin, 94163 Saint-Mandé, France.
出版信息
Antimicrob Agents Chemother. 2002 Jul;46(7):2307-9. doi: 10.1128/AAC.46.7.2307-2309.2002.
Abstract
Ninety-six isolates of Bacillus anthracis recovered in France between 1994 and 2000 were tested for their susceptibilities to 25 different antibiotics. Resistance to penicillin G and amoxicillin was 11.5%. All of the isolates were resistant to cotrimoxazole and susceptible to doxycycline, ciprofloxacin, pefloxacin, levofloxacin, teicoplanin, vancomycin, clindamycin, imipenem, and rifampin.
摘要
对1994年至2000年间在法国分离出的96株炭疽芽孢杆菌进行了25种不同抗生素的药敏试验。对青霉素G和阿莫西林的耐药率为11.5%。所有分离株对复方新诺明耐药，对强力霉素、环丙沙星、培氟沙星、左氧氟沙星、替考拉宁、万古霉素、克林霉素、亚胺培南和利福平敏感。
相似文献
1
Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.
Antimicrob Agents Chemother. 2002 Jul;46(7):2307-9. doi: 10.1128/AAC.46.7.2307-2309.2002.
2
Antimicrobial susceptibilities of 40 isolates of Bacillus anthracis isolated in Turkey.
Int J Antimicrob Agents. 2003 Jul;22(1):70-2. doi: 10.1016/s0924-8579(03)00097-9.
3
Antimicrobial susceptibility of Bacillus anthracis strains from Hungary.
Acta Vet Hung. 2016 Jun;64(2):141-7. doi: 10.1556/004.2016.015.
4
Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare.
Clin Microbiol Infect. 2003 Sep;9(9):984-6. doi: 10.1046/j.1469-0691.2003.00775.x.
5
Selection of Bacillus anthracis isolates resistant to antibiotics.
J Antimicrob Chemother. 2004 Aug;54(2):424-8. doi: 10.1093/jac/dkh258. Epub 2004 Jun 17.
6
Antimicrobial susceptibility testing of Bacillus anthracis: comparison of results obtained by using the National Committee for Clinical Laboratory Standards broth microdilution reference and Etest agar gradient diffusion methods.
J Clin Microbiol. 2002 Jun;40(6):1902-7. doi: 10.1128/JCM.40.6.1902-1907.2002.
7
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Antimicrob Agents Chemother. 2015 Dec;59(12):7497-503. doi: 10.1128/AAC.01376-15. Epub 2015 Sep 21.
8
Evaluation of Combination Drug Therapy for Treatment of Antibiotic-Resistant Inhalation Anthrax in a Murine Model.
Antimicrob Agents Chemother. 2017 Aug 24;61(9). doi: 10.1128/AAC.00788-17. Print 2017 Sep.
9
MICs of selected antibiotics for Bacillus anthracis, Bacillus cereus, Bacillus thuringiensis, and Bacillus mycoides from a range of clinical and environmental sources as determined by the Etest.
J Clin Microbiol. 2004 Aug;42(8):3626-34. doi: 10.1128/JCM.42.8.3626-3634.2004.
10
Evaluation of antimicrobial susceptibility of strains isolated during anthrax outbreaks in Italy from 1984 to 2017.
J Vet Sci. 2019 Jan 31;20(1):58-62. doi: 10.4142/jvs.2019.20.1.58.
引用本文的文献
1
An evaluation of antibiotic options for the treatment of biothreat pathogens.
Front Antibiot. 2025 Aug 14;4:1611588. doi: 10.3389/frabi.2025.1611588. eCollection 2025.
2
Anthrax: A narrative review.
New Microbes New Infect. 2024 Oct 10;62:101501. doi: 10.1016/j.nmni.2024.101501. eCollection 2024 Dec.
3
Rational corticosteroids administration and antibiotic treatment is key to managing cutaneous anthrax.
BMC Infect Dis. 2024 Oct 31;24(1):1225. doi: 10.1186/s12879-024-09922-9.
4
Anthrax in Humans, Animals, and the Environment and the One Health Strategies for Anthrax Control.
Pathogens. 2024 Sep 7;13(9):773. doi: 10.3390/pathogens13090773.
5
Antimicrobial Resistance Profile, Whole-Genome Sequencing and Core Genome Multilocus Sequence Typing of Isolates in Croatia from 2001 to 2022.
Antibiotics (Basel). 2024 Jul 11;13(7):639. doi: 10.3390/antibiotics13070639.
6
Genetic basis of clarithromycin resistance in .
Microbiol Spectr. 2024 Jun 4;12(6):e0418023. doi: 10.1128/spectrum.04180-23. Epub 2024 Apr 26.
7
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023.
MMWR Recomm Rep. 2023 Nov 17;72(6):1-47. doi: 10.15585/mmwr.rr7206a1.
8
Recombinant full-length protective antigen and its 63 kDa form elicits protective response in formulation with addavax.
Front Immunol. 2023 Jan 12;13:1075662. doi: 10.3389/fimmu.2022.1075662. eCollection 2022.
9
Risk Factors for Severe Cutaneous Anthrax in a Retrospective Case Series and Use of a Clinical Algorithm to Identify Likely Meningitis and Evaluate Treatment Outcomes, Kyrgyz Republic, 2005-2012.
Clin Infect Dis. 2022 Oct 17;75(Suppl 3):S478-S486. doi: 10.1093/cid/ciac537.
10
Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947-2019.
Clin Infect Dis. 2022 Oct 17;75(Suppl 3):S373-S378. doi: 10.1093/cid/ciac520.
本文引用的文献
1
In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne.
Antimicrob Agents Chemother. 2000 Jun;44(6):1766. doi: 10.1128/AAC.44.6.1766-1766.2000.
2
Inhalational anthrax: epidemiology, diagnosis, and management.
Chest. 1999 Nov;116(5):1369-76. doi: 10.1378/chest.116.5.1369.
3
The medical threat of biological weapons.
Crit Rev Microbiol. 1998;24(3):157-68. doi: 10.1080/10408419891294280.
4
Bacillus thuringiensis subsp. konkukian (serotype H34) superinfection: case report and experimental evidence of pathogenicity in immunosuppressed mice.
J Clin Microbiol. 1998 Jul;36(7):2138-9. doi: 10.1128/JCM.36.7.2138-2139.1998.
5
Identification and characterization of Bacillus anthracis by multiplex PCR analysis of sequences on plasmids pXO1 and pXO2 and chromosomal DNA.
FEMS Microbiol Lett. 1996 Nov 15;145(1):9-16. doi: 10.1111/j.1574-6968.1996.tb08548.x.
6
A macrolide-lincosamide-streptogramin B resistance determinant from Bacillus anthracis 590: cloning and expression of ermJ.
J Gen Microbiol. 1993 Mar;139(3):601-7. doi: 10.1099/00221287-139-3-601.
7
Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979.
Proc Natl Acad Sci U S A. 1993 Mar 15;90(6):2291-4. doi: 10.1073/pnas.90.6.2291.
8
Bacillus cereus and related species.
Clin Microbiol Rev. 1993 Oct;6(4):324-38. doi: 10.1128/CMR.6.4.324.
9
[Characterization of a Rif-R population of Bacillus anthracis].
Antibiot Khimioter. 1993 Aug-Sep;38(8-9):34-8.
10
Outbreak of oral-oropharyngeal anthrax: an unusual manifestation of human infection with Bacillus anthracis.
Am J Trop Med Hyg. 1984 Jan;33(1):144-50. doi: 10.4269/ajtmh.1984.33.144.
Zotero 插件